Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Part of paid clinical trials in New York, New York.

Sponsor
Efforia, Inc
Study ID
NCT07717385
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety Symptoms
  • Depressive Symptoms
  • Occupational Burnout
  • Psychological Stress
  • Sleep Disturbance

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Neuralli Mood — DIETARY_SUPPLEMENT
    Two acid-resistant capsules taken once daily for 90 days. Each daily dose contains 30 billion CFU of L. plantarum PS128 and 20 billion heat-treated cells of L. paracasei PS23. Other ingredients include microcrystalline cellulose, hypromellose, pectin, glycerol, silica, and magnesium stearate.

Study Details

This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.

Key Dates

First listed
Jul 21, 2026
Start date
Jun 30, 2026
Status verified
Jul 2026
Primary completion
Sep 28, 2027
Completion
Sep 28, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Neuralli Mood Supplementation
    Participants take two capsules of Neuralli Mood once daily, with or without food, at a consistent time for 90 days and complete scheduled study assessments and safety check-ins.

Primary Outcome Measure

Change in Depression Anxiety and Stress Scales-21 Stress Subscale Score [ Time Frame: Baseline before the first dose and end of the 90-day supplementation period ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Efforia - Decentralized United States StudyNew YorkNew York10003
Matthew Amsden
[email protected]
Matthew Amsden (PRINCIPAL_INVESTIGATOR)
Viral Patel (SUB_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Efforia - Decentralized United States Study· New York, NY

Related Studies